Established self-pay plastic surgery and medical aesthetics practice generates roughly $2.5M annual revenue with recent adjusted EBITDA between about $750k and $950k and operating margins ranging from the high teens to mid-30s over the last several years. The practice serves patients from multiple nearby metro areas in an affluent Midwestern suburban market, completing more than 2,300 appointments each year and drawing over 80% of its base from women aged 30–60 who often return for additional procedures over extended periods.

The business delivers a comprehensive mix of breast and body-contouring surgery, facial rejuvenation, and non-surgical services including injectables, PRP, Morpheus8, Ultherapy, CoolSculpting, CO2 resurfacing, and chemical peels. Surgical work generates about 60% of net income, with the remainder coming from OR fees, non-surgical procedures, and product sales, creating diversified revenue across discretionary but high-repeat categories. A pure self-pay model, no equipment debt, and a strong online reputation supported by a 4.5-star rating across more than 240 reviews support attractive cash flow and resilient patient loyalty.

Operations run from an AAAA-SF certified Class C OR and approximately 4,500 square feet of dedicated space within a multi-unit medical building on roughly 1.5 acres, with additional tenant-occupied units that offer future expansion or real estate income if acquired. Board certification in plastic surgery, formal accreditation, and an experienced non-union team underpin clinical quality and institutional trust. The owner seeks a retirement transition and remains open to a structured 3–5 year handover, giving an incoming buyer time to onboard an associate surgeon, scale marketing, expand OR capacity, and add wellness, longevity, hormone, and weight-loss programs for incremental recurring revenue.